Apogee Therapeutics Inc. (APGE) at a glance

Apogee Therapeutics Inc. (APGE) is a mid-cap Healthcare company. It trades at $135.11, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 59/100 overall. Its strongest dimension is Momentum (87/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$135.11

Market cap

$6.66B

P/E ratio

n/a

Dividend yield

None

Beta

0.62

52-week range

$35.39 to $134.99